Form D · Pharmaceuticals
Propanc Biopharma, Inc.
Camberwell, Vic, C3 · CIK 0001517681
Offering snapshot reported Nov 3, 2023 · SEC filing
- Reported sold
- $40K Offering amount: $40K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $40K Reported outside-investor minimum
- First sale
- Oct 20, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 3, 2023 | Initial | $40,000 | No comparison | 1 | SEC filing |
| Oct 26, 2023 | Initial | $61,000 | No comparison | 1 | SEC filing |
| Aug 31, 2023 | Initial | $72,500 | No comparison | 1 | SEC filing |
| Aug 31, 2023 | Initial | $55,000 | No comparison | 1 | SEC filing |
| Aug 30, 2023 | Initial | $120,000 | No comparison | 1 | SEC filing |
| Aug 16, 2023 | Initial | $65,000 | No comparison | 1 | SEC filing |
| Aug 15, 2023 | Initial | $45,000 | No comparison | 1 | SEC filing |
| Apr 17, 2020 | Initial | $450,000 | No comparison | 1 | SEC filing |
| Jan 2, 2019 | Initial | $105,000 | No comparison | 1 | SEC filing |
| Jan 2, 2019 | Initial | $126,000 | No comparison | 1 | SEC filing |
| Oct 11, 2018 | Initial | $422,000 | No comparison | 2 | SEC filing |
| Oct 1, 2018 | Initial | $6,315,435 | No comparison | 8 | SEC filing |
| Sep 17, 2018 | Initial | $158,000 | No comparison | 2 | SEC filing |
| May 8, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 4, 2012 | Initial | $30,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-496483
Source: Form D, filed Nov 3, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carlo Campiciano | Executive |
| J Ulian Kenyon | Director |
| Julian Kenyon | Director, Executive |
| Douglas Mitchell | Director, Executive |
| James Nathanielsz | Director, Executive |
| Josef Zelinger | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
302, 6 Butler Street
Camberwell, Vic, C3, 3124
Camberwell, Vic, C3, 3124